N-(2,4,5-trihydroxyphenethyl)normetazocine, a potential irreversible inhibitor of the narcotic receptor

DOI: 10.1021/jm00215a011

Source and publish data:

Journal of Medicinal Chemistry p. 673 - 675 (1977)

Update date:2022-07-29

Topics:

Authors:

Rice Rice

Shiotani

Creveling

Jacobson

Klee Klee

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/jm00215a011

The reaction of N-(2,4,5-tribenzyloxyphenyl)ethyl methanesulfonate, prepared in a seven-step sequence, with normetazocine followed by hydrogenolysis of the benzyloxy-protecting groups, gave N-(2,4,5-trihydroxyphenethyl)normetazocine. This compound was pre

Full text of DOI:10.1021/jm00215a011

Products guided by the article

Product name:6,11-Dimethyl-3-[2-(2,4,5-tris-benzyloxy-phenyl)-ethyl]-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol

Cas No:62208-99-5

R&D Labs maybe for 62208-99-5

Chinese Peptide Company

Contact:86-571-86737118-8689

Address:No.69, 12 Street, HEDA, Hangzhou, Zhejiang, China
Buffett (China) Holding Co.,Ltd

Contact:4006570891

Address:
Wuxi Innopal International Trade CO.,LTD

Contact:+86-510-80711901-8003

Address:Room 402,Building 5,Longze Garden,No.17,South huanjiu Road,Yixing City, Jiangsu,China
SJZ Chenghui Chemical Co., Ltd.

Contact:86-311-87713916

Address:no.368 youyi north avenue
Rizhao Lanxing Chemical Indusrial Co.,Ltd

Contact:86-633-2616708

Address:NO.15 West road Shenglan, Lanshan district, Rizhao City

Relevant to this article

Doi:10.1021/ja00446a050
(1977)
Doi:10.1016/S0040-4039(00)92568-1
(1976)
Doi:10.1007/BF00759995
()
Hydrophobically Directed Selective Reduction of Ketones

Doi:10.1021/ja0379924
(2003)
The structure of the antibiotic perimycin A

Doi:10.1016/S0040-4039(00)92971-X
(1976)
In Vivo Studies on the Metabolism of the Monoterpene Pulegone in Humans Using the Metabolism of Ingestion-Correlated Amounts (MICA) Approach: Explanation for the Toxicity Differences between (S)-(-)- and (R)-(+)-Pulegone

Doi:10.1021/jf034702u
(2003)

Article Doi